Skip to Main Content

Author Details

Aneesh K Mehta
Emory University School of Medicine
2009
99
38
PMIDPaper TitleJournal TitlePublished Year
37383244Evaluating Demographic Representation in Clinical Trials: Use of the Adaptive Coronavirus Disease 2019 Treatment Trial (ACTT) as a Test Case.Open Forum Infect Dis2023
37910603Fecal microbiota transplantation promotes reduction of antimicrobial resistance by strain replacement.Sci Transl Med2023
37383244Evaluating Demographic Representation in Clinical Trials: Use of the Adaptive Coronavirus Disease 2019 Treatment Trial (ACTT) as a Test Case.Open Forum Infect Dis2023
37910603Fecal microbiota transplantation promotes reduction of antimicrobial resistance by strain replacement.Sci Transl Med2023
34050745Reply to author.Clin Infect Dis2022
35395384Lassa Virus Infection: a Summary for Clinicians.Int J Infect Dis2022
35818363Unraveling the Treatment Effect of Baricitinib on Clinical Progression and Resource Utilization in Hospitalized COVID-19 Patients: Secondary Analysis of the Adaptive COVID-19 Treatment Randomized Trial-2.Open Forum Infect Dis2022
35483093Prepared to Act: Lessons Learned by the Special Pathogens Research Network, Based on Collaborations with the NIAID-Led Adaptive COVID-19 Treatment Trial.Health Secur2022
35483049Contributions of the Regional Emerging Special Pathogen Treatment Centers to the US COVID-19 Pandemic Response.Health Secur2022
36321801Impact of belatacept and tacrolimus on cytomegalovirus viral load control and relapse in moderate and high-risk cytomegalovirus serostatus kidney transplant recipients.Transpl Infect Dis2022
36442063Temporal Improvements in COVID-19 Outcomes for Hospitalized Adults: A Post Hoc Observational Study of Remdesivir Group Participants in the Adaptive COVID-19 Treatment Trial.Ann Intern Med2022
34050745Reply to author.Clin Infect Dis2022
34133889Fecal Microbiota Transplantation Donor Screening Updates and Research Gaps for Solid Organ Transplant Recipients.J Clin Microbiol2022
33822023Racial and Ethnic Differences and Clinical Outcomes of Patients With Coronavirus Disease 2019 (COVID-19) Presenting to the Emergency Department.Clin Infect Dis2022
34409989Deconstructing the Treatment Effect of Remdesivir in the Adaptive Coronavirus Disease 2019 (COVID-19) Treatment Trial-1: Implications for Critical Care Resource Utilization.Clin Infect Dis2022
34453519National Landscape of Human Immunodeficiency Virus-Positive Deceased Organ Donors in the United States.Clin Infect Dis2022
35395384Lassa Virus Infection: a Summary for Clinicians.Int J Infect Dis2022
35818363Unraveling the Treatment Effect of Baricitinib on Clinical Progression and Resource Utilization in Hospitalized COVID-19 Patients: Secondary Analysis of the Adaptive COVID-19 Treatment Randomized Trial-2.Open Forum Infect Dis2022
35483093Prepared to Act: Lessons Learned by the Special Pathogens Research Network, Based on Collaborations with the NIAID-Led Adaptive COVID-19 Treatment Trial.Health Secur2022
35483049Contributions of the Regional Emerging Special Pathogen Treatment Centers to the US COVID-19 Pandemic Response.Health Secur2022
36442063Temporal Improvements in COVID-19 Outcomes for Hospitalized Adults: A Post Hoc Observational Study of Remdesivir Group Participants in the Adaptive COVID-19 Treatment Trial.Ann Intern Med2022
36321801Impact of belatacept and tacrolimus on cytomegalovirus viral load control and relapse in moderate and high-risk cytomegalovirus serostatus kidney transplant recipients.Transpl Infect Dis2022
33822023Racial and Ethnic Differences and Clinical Outcomes of Patients With Coronavirus Disease 2019 (COVID-19) Presenting to the Emergency Department.Clin Infect Dis2022
34409989Deconstructing the Treatment Effect of Remdesivir in the Adaptive Coronavirus Disease 2019 (COVID-19) Treatment Trial-1: Implications for Critical Care Resource Utilization.Clin Infect Dis2022
34453519National Landscape of Human Immunodeficiency Virus-Positive Deceased Organ Donors in the United States.Clin Infect Dis2022
34133889Fecal Microbiota Transplantation Donor Screening Updates and Research Gaps for Solid Organ Transplant Recipients.J Clin Microbiol2022
32519434CMV high-risk status and posttransplant outcomes in kidney transplant recipients treated with belatacept.Am J Transplant2021
33948610Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells.medRxiv2021
33993599Clinical characteristics and outcomes of toxoplasmosis among transplant recipients at two US academic medical centers.Transpl Infect Dis2021
33879560Answer to May 2021 Photo Quiz.J Clin Microbiol2021
33879559Photo Quiz: Strength in Numbers-a Disseminated Infection Causing Shortness of Breath.J Clin Microbiol2021
34250512Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells.Cell Rep Med2021
33756063TIGIT regulates apoptosis of risky memory T cell subsets implicated in belatacept-resistant rejection.Am J Transplant2021
33306283Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19.N Engl J Med2021
32748558Adenovirus causing hepatic abscess formation and unexplained fever in adult liver transplant recipients.Transpl Infect Dis2021
32519434CMV high-risk status and posttransplant outcomes in kidney transplant recipients treated with belatacept.Am J Transplant2021
33290629Cryptococcus transmission through solid organ transplantation in the United States: A report from the Ad Hoc Disease Transmission Advisory Committee.Am J Transplant2021
32894634Donor derived hepatitis B virus infection: Analysis of the Organ Procurement & Transplantation Network/United Network for Organ Sharing Ad Hoc Disease Transmission Advisory Committee.Transpl Infect Dis2021
34386544Human Adenovirus 11 in 2 Renal Transplant Recipients: Suspected Donor-Derived Infection.Open Forum Infect Dis2021
33879560Answer to May 2021 Photo Quiz.J Clin Microbiol2021
33879559Photo Quiz: Strength in Numbers-a Disseminated Infection Causing Shortness of Breath.J Clin Microbiol2021
33756063TIGIT regulates apoptosis of risky memory T cell subsets implicated in belatacept-resistant rejection.Am J Transplant2021
34386544Human Adenovirus 11 in 2 Renal Transplant Recipients: Suspected Donor-Derived Infection.Open Forum Infect Dis2021
33993599Clinical characteristics and outcomes of toxoplasmosis among transplant recipients at two US academic medical centers.Transpl Infect Dis2021
34250512Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells.Cell Rep Med2021
33948610Longitudinal analysis shows durable and broad immune memory after SARS-CoV-2 infection with persisting antibody responses and memory B and T cells.medRxiv2021
33306283Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19.N Engl J Med2021
33290629Cryptococcus transmission through solid organ transplantation in the United States: A report from the Ad Hoc Disease Transmission Advisory Committee.Am J Transplant2021
32748558Adenovirus causing hepatic abscess formation and unexplained fever in adult liver transplant recipients.Transpl Infect Dis2021
32894634Donor derived hepatitis B virus infection: Analysis of the Organ Procurement & Transplantation Network/United Network for Organ Sharing Ad Hoc Disease Transmission Advisory Committee.Transpl Infect Dis2021
  • 1 - 50 of 198

Recommended Authors

Yale School of Medicine, Yale University
Career Start Year 2014
Number of shared co-authors 2
Weill Cornell Medical College, New York-Presbyterian Hospital
Career Start Year 2014
Number of shared co-authors 0
University of South Florida
Career Start Year 2010
Number of shared co-authors 1
Mayo Foundation for Medical Education and Research
Career Start Year 2009
Number of shared co-authors 0
University of Kansas Medical Center
Career Start Year 2006
Number of shared co-authors 1
Mayo Clinic
Career Start Year 2004
Number of shared co-authors 1
University of Minnesota
Career Start Year 2003
Number of shared co-authors 4
Yale University School of Medicine
Career Start Year 2002
Number of shared co-authors 2
NanoString Technologies Inc.
Career Start Year 2002
Number of shared co-authors 1
Center for Infectious Diseases Research, Walter Reed Army Institute of Research
Career Start Year 2002
Number of shared co-authors 7
Vitalant Research Institute, USA University of California san francisco
Career Start Year 2001
Number of shared co-authors 8
Northwestern University Feinberg School of Medicine
Career Start Year 2000
Number of shared co-authors 1
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Career Start Year 1999
Number of shared co-authors 3
Federal University of Rio de Janeiro
Career Start Year 1998
Number of shared co-authors 1
Department of Microbial Pathogenesis Yale University New Haven
Career Start Year 1998
Number of shared co-authors 0
University of California los angeles
Career Start Year 1998
Number of shared co-authors 1
Mayo Clinic
Career Start Year 1994
Number of shared co-authors 0
Johns Hopkins School of Medicine, Johns Hopkins University
Career Start Year 1993
Number of shared co-authors 7
Hospital Universitario de Guadalajara
Career Start Year 1991
Number of shared co-authors 2
Fred Hutchinson Cancer Center
Career Start Year 1991
Number of shared co-authors 3
Mount Sinai Health System and University Health Network
Career Start Year 1989
Number of shared co-authors 2
Northwestern University, Feinberg Northwestern School of Medicine
Career Start Year 1988
Number of shared co-authors 1
University of Utah
Career Start Year 1987
Number of shared co-authors 5
VA Medical Center
Career Start Year 1986
Number of shared co-authors 2
Feinberg School of Medicine, Northwestern University
Career Start Year 1984
Number of shared co-authors 0
Perelman School of Medicine, the University of Pennsylvania
Career Start Year 1983
Number of shared co-authors 0
University of Rochester Medical Center
Career Start Year 1983
Number of shared co-authors 4
David Geffen School of Medicine, University of California los angeles
Career Start Year 1982
Number of shared co-authors 2
Icahn School of Medicine at Mount Sinai
Career Start Year 1981
Number of shared co-authors 3
University of Miami, Miller School of Medicine
Career Start Year 1977
Number of shared co-authors 2

Collaborators

Emory University School of Medicine
Co-authored papers 26
Emory University School of Medicine
Co-authored papers 25
Emory University School of Medicine
Co-authored papers 16
Co-authored papers 16
Co-authored papers 13
Co-authored papers 11
US Centers for Disease Control and Prevention
Co-authored papers 11
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Co-authored papers 9
Co-authored papers 8
Christchurch Hospital
Co-authored papers 6
Infectious Disease Clinical Research Program, Uniformed Services University
Co-authored papers 5
University of Nebraska Medical Center
Co-authored papers 5
Co-authored papers 5
Co-authored papers 5
Institute for Immunity, Stanford University School of Medicine, Stanford University
Co-authored papers 5
University of Nebraska School of Medicine
Co-authored papers 5
Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology
Co-authored papers 5
College of Allied Health Professions, University of Nebraska Medical Center
Co-authored papers 4
Co-authored papers 4
Co-authored papers 4
Co-authored papers 4
Co-authored papers 4
Co-authored papers 4
Co-authored papers 4
Goethe University Frankfurt, University Hospital
Co-authored papers 4
Co-authored papers 3
Division of Clinical Research, National Institutes of Allergy and Infectious Diseases
Co-authored papers 3
Co-authored papers 3
University Hospital of Geneva
Co-authored papers 3
Drukier Institute for Children's Health
Co-authored papers 3